Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

microTargeting Guideline 4000 5.0 System

K-Number: K183123 · 2018-12-20

ApplicantFHC, Inc.
Decision Date2018-12-20
Product CodeGZL
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

microTargeting Guideline 4000 5.0 System is the device name listed in this FDA 510(k) record. The listed applicant is FHC, Inc.. It received FDA 510(k) clearance on 2018-12-20 under 510(k) number K183123. The device is classified under product code GZL. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the microTargeting Guideline 4000 5.0 System?

microTargeting Guideline 4000 5.0 System is a medical device that received FDA 510(k) clearance on 2018-12-20. The listed applicant is FHC, Inc.. The 510(k) number is K183123.

When did microTargeting Guideline 4000 5.0 System receive FDA 510(k) clearance?

microTargeting Guideline 4000 5.0 System received FDA 510(k) clearance on 2018-12-20, under 510(k) number K183123.

Who is the listed applicant for microTargeting Guideline 4000 5.0 System?

The FDA 510(k) record lists FHC, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for microTargeting Guideline 4000 5.0 System?

The FDA product code for microTargeting Guideline 4000 5.0 System is GZL.

Other records listing FHC, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GZL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.